CN101213998A - Health-care Pu' er tea capable of resisting HIV virus and improving human immunity - Google Patents
Health-care Pu' er tea capable of resisting HIV virus and improving human immunity Download PDFInfo
- Publication number
- CN101213998A CN101213998A CNA2008100580228A CN200810058022A CN101213998A CN 101213998 A CN101213998 A CN 101213998A CN A2008100580228 A CNA2008100580228 A CN A2008100580228A CN 200810058022 A CN200810058022 A CN 200810058022A CN 101213998 A CN101213998 A CN 101213998A
- Authority
- CN
- China
- Prior art keywords
- tea
- care
- health
- human body
- juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000020339 pu-erh tea Nutrition 0.000 title claims abstract description 94
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 title claims abstract description 90
- 241000725303 Human immunodeficiency virus Species 0.000 title claims abstract description 52
- 230000036039 immunity Effects 0.000 title abstract description 4
- 244000269722 Thea sinensis Species 0.000 claims abstract description 43
- 235000013616 tea Nutrition 0.000 claims abstract description 41
- 108090000790 Enzymes Proteins 0.000 claims abstract description 19
- 102000004190 Enzymes Human genes 0.000 claims abstract description 19
- 235000015097 nutrients Nutrition 0.000 claims abstract description 18
- 241000222336 Ganoderma Species 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 39
- 239000003814 drug Substances 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 19
- 229940088598 enzyme Drugs 0.000 claims description 18
- 230000036737 immune function Effects 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 16
- 240000004638 Dendrobium nobile Species 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 13
- 208000030507 AIDS Diseases 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 238000007796 conventional method Methods 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000019419 proteases Nutrition 0.000 claims description 5
- 108010004032 Bromelains Proteins 0.000 claims description 4
- 108090000526 Papain Proteins 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 235000019987 cider Nutrition 0.000 claims description 4
- 235000009569 green tea Nutrition 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 210000004243 sweat Anatomy 0.000 claims description 4
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 240000008918 Chaenomeles cathayensis Species 0.000 claims description 2
- 235000009810 Chaenomeles cathayensis Nutrition 0.000 claims description 2
- 244000241235 Citrullus lanatus Species 0.000 claims description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims description 2
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 241000218996 Passiflora Species 0.000 claims description 2
- 244000294611 Punica granatum Species 0.000 claims description 2
- 235000014360 Punica granatum Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 239000003708 ampul Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 235000019674 grape juice Nutrition 0.000 claims description 2
- 235000015205 orange juice Nutrition 0.000 claims description 2
- 239000003182 parenteral nutrition solution Substances 0.000 claims description 2
- 235000013944 peach juice Nutrition 0.000 claims description 2
- 235000015206 pear juice Nutrition 0.000 claims description 2
- 235000013997 pineapple juice Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 20
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 210000000987 immune system Anatomy 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000002496 gastric effect Effects 0.000 abstract description 2
- 230000031891 intestinal absorption Effects 0.000 abstract description 2
- 241000305491 Gastrodia elata Species 0.000 abstract 2
- 210000002865 immune cell Anatomy 0.000 abstract 2
- 241001523681 Dendrobium Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 25
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 23
- 238000012360 testing method Methods 0.000 description 10
- 231100001274 therapeutic index Toxicity 0.000 description 9
- 230000000120 cytopathologic effect Effects 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010001497 Agitation Diseases 0.000 description 3
- 208000031886 HIV Infections Diseases 0.000 description 3
- 206010019851 Hepatotoxicity Diseases 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000009194 climbing Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000007686 hepatotoxicity Effects 0.000 description 3
- 231100000304 hepatotoxicity Toxicity 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- 235000000173 Camellia sinensis var sinensis Nutrition 0.000 description 1
- 240000007524 Camellia sinensis var. sinensis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 238000011225 antiretroviral therapy Methods 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides health-care Pu' er tea for resisting HIV and improving human immunity, which consists of the following raw materials in percentage by mass: 30-50% of Pu' er tea, 10-20% of dendrobium, 10-20% of ginseng, 5-10% of poria cocos, 10-20% of gastrodia elata and 8-18% of lucid ganoderma. The post-fermentation tea is added with ganoderma lucidum, gastrodia elata fungus substances and medicinal components capable of refreshing and tonifying qi in the fermentation process besides biological enzyme nutrient solution, has the effects of alleviating damage of immune cells, promoting recovery of damaged immune cells, adjusting intestinal absorption environment, improving the immune system of a human body, gastrointestinal absorption and the like, and more importantly has a strong inhibiting effect on HIV (human immunodeficiency virus).
Description
Technical field
The present invention relates to the health-care pu'er tea of a kind of AIDS virus resisting (HIV), and the application in preparation control AIDS-treating medicine.
Background technology
AIDS is fast because of its spread speed, scope is wide, and up to the present, and still do not have effective medicine and it is controlled and prevent, thereby become the viral infectious of current social influence maximum, be one of major disease that jeopardizes human body health.The research to the AIDS preventing and controlling medicine is all paid attention in countries in the world in recent years, and has strengthened research and dropped into, but still does not make a breakthrough.Though the employing highly active antiretroviral therapy that has to improve patient's illness, increases CD
4Problems such as cell quantity reduce virus, but because of there is the medical expense costliness in it, toxic and side effect is big, can not block the early infection process of HIV, and the HIV variation is fast are difficult to allow the patient bear, and also are difficult to obtain effectively to prevent simultaneously vaccine and medicine.The existing in addition Chinese herbal medicine of preventing and treating AIDS also exists human body difference big, and curative effect is not remarkable, the not first-class problems of prevention effect.Therefore, prevent the HIV variation, treat the high-efficiency low-toxicity medicine of AIDS (aids) pathology, remain the key subjects of worldwide research inverase.
Pu'er tea is the important a member in China tea beverage family, the fermentation processing technology of its uniqueness, give the characteristic that Pu'er tea is mellow, aromatic, the soup look gorgeous, allow Pu'er tea outside being rich in tealeaves intrinsic abundant nutrition composition such as catechin, tannin, aromatic oil, vitamin C, B, D and trace element, also contain multiple disease preventing and treating, help strengthening body immunity, improve human health level's benefit materials.But so far for this reason, do not see the report that Pu'er tea is used as yet in preparation control AIDS-treating medicine and health products, do not see the report of health-care pu'er tea product yet with control AIDS virus HIV.
Summary of the invention
Purpose of the present invention just provides a kind of AIDS virus resisting HIV, improves the health-care pu'er tea of immune function of human body.
The object of the present invention is achieved like this: the health-care pu'er tea of a kind of AIDS virus resisting HIV, raising immune function of human body is characterized in that being made up of the raw material of following mass ratio:
Pu'er tea 30～50%
The stem of noble dendrobium 10～20%
Genseng 10～20%
Poria cocos 5～10%
Rhizoma Gastrodiae 10～20%
Glossy ganoderma 8～18%.
Described health-care pu'er tea makes through following method:
A, elder generation extract the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material respectively through following method: raw material pulverizing is powdered, be soaked in water 3～5 hours, and under 80 ℃ of temperature, heated 2～4 hours, filter, concentrated filtrate, concentration is 30～50% extract;
B, Pu'er tea and biology enzyme nutrient solution mixed by 1: 0.1～0.3 mass ratio after, mix with the full dose of each extract of A step gained again, wherein, the biology enzyme nutrient solution is made up of following component by mass percent:
Hydrolysising protease 0.1～0.3%
Glucose 10～35%
Fruit drink 15～30%
Water surplus;
C, B step gained mixture is packed in the case, temperature is under the 40-65 ℃ of condition in the mixture heap, ferments 20-25 days, promptly gets health-care pu'er tea;
D, step C gained fermented health-care Pu'er tea is made loose tea, fannings, cake tea, Tuo tea, sugar tea, the tea in bag of health care products, promptly get AIDS virus resisting HIV, improve the health-care pu'er tea product of immune function of human body.
It highly is rectangle or the circle or the polygon casing of 0.8-1 rice that the vanning fermentation of described C step is adopted, and carries out under the situation of case mouth capping, to improve ferment effect, satisfies the fermentation hygienic requirements.
The hydrolysising protease of described B step is a kind of in bromelain, the papain; Fruit drink is one or more in pear juice, cider, peach juice, watermelon juice, pineapple juice, mango juice, grape juice, Passiflora juice, Cantaloupe juice, Chinese flowering quince juice, orange juice, the juice of my pomegranate.
The pH value of the biology enzyme nutrient solution of described B step is 4.5～6.5.
The control of humidity in the described sweat is 10～30% to exceed with material moisture, and water content many and few are decided by the moisture of material in the water content of solar dried green tea and other raw material self and the sweat again.
Described Pu'er tea is that the solar dried green tea of big-leaf species in yunnan tea (has another name called: Pu'er raw tea).
It is 200610010625.1 in the patent No. of on January 11st, 2006 application that described health-care pu'er tea also can adopt the applicant, and name is called the method for Chinese patent of " a kind of method with the fermented by biological enzyme Pu'er tea " and layering stand ferments and get, that is:
A, the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material pulverizing is powdered, after Pu'er tea fully mixes, mixture;
B, the mixture with the A step, water and biology enzyme nutrient solution mix by following mass ratio;
1∶0.4～0.6∶0.1～0.3
Wherein, the biology enzyme nutrient solution is made up of following component by mass percent:
Hydrolysising protease 0.1～0.3%
Glucose 10～35%
Fruit drink 15～30%
Water surplus;
C, mixed above-mentioned tealeaves mixture is deposited on the stand of layering, controlling every layer of tealeaves height is 40-70cm;
D, be under the 40-65 ℃ of condition, fermented 20-25 days, promptly get health-care pu'er tea at the tea stack temperature;
E, make loose tea, fannings, cake tea, Tuo tea, sugar tea, the tea in bag of health care products, promptly get AIDS virus resisting HIV, improve the health-care pu'er tea product of immune function of human body with the existing conventional processing method.
Layering stand wherein is made of space framework and the horizontal platen that is arranged at intervals on the space framework, and horizontal platen is made as stationary platen, perhaps the drawing and pulling type movable mold; Space framework is set to rectangular frame or triangular framing or cylindrical frame or polygonal frame, at interval horizontal support member is set on the framework, places fixing or movable mold on the support member; The horizontal support member in twos on the framework or the spacing of horizontal platen are 70-85cm.
Above-mentioned gained health-care pu'er tea can be made loose tea, fannings, cake tea, Tuo tea, sugar tea, the tea in bag of compound health-care category with other drug regimens of preventing and treating AIDS.
After described health-care pu'er tea can the conventional method by prior art extracts, the conventional method that adopts prior art again was with the extract obtained oral formulations that allows on the pharmacy such as capsule, tablet, electuary, the oral liquid etc. of being prepared into.
Described health-care pu'er tea extract can be prepared into the ejection preparation that allows on the pharmacy such as parenteral solution, powder ampoule agent for injection, injection emulsion etc. by the conventional method of prior art.
Described health-care pu'er tea extract can be made compound oral administration preparation or the compound injection that allows on the pharmacy with other drug regimens of preventing and treating AIDS.
Described medicine is Chinese herbal medicine or Western medicine.
The use amount adult who adopts can be:
Directly the health-related product made from health-care pu'er tea be 5～10 grams/time, every day 1～3 time.
The health-related product made from the health-care pu'er tea extract be 0.15～0.2 gram/time, every day 1～3 time.
In the traditional Chinese medicine ingredients in the health-care pu'er tea provided by the invention, the sweet flat profit of its property of rhizoma Gastrodiae has breath wind and ends convulsion, the effect of removing obstruction in channels to relieve pain; It is warm in nature for glossy ganoderma, and bitter and puckery flavor can nourishing and body-strengthening, strengthens the body resistance to consolidate the constitution, enhances metabolism and delay senility, and the body immune system improves the resistivity of human body to disease; Its flavor of the stem of noble dendrobium is sweet, light, and cold nature can improve the SOP (super chlorine mutase) in the human body, reduces CPO (superchlorination lipid); Its property sweet and slightly bitter taste of genseng, temperature, have take off admittedly promote the production of body fluid, the effect of tranquilizing and blood nourishing; Its property slightly sweet flavor of Poria cocos, flat has eliminating dampness and diuresis, the effect of beneficial spleen and stomach antitoxic heart-soothing and sedative.
Health-care pu'er tea provided by the invention is a kind of after fermentation tea, during the fermentation except that adding the biology enzyme nutrient solution, also add glossy ganoderma, day crudefiber crop fungi material, and the drug ingedient of the tonifying Qi of refreshing oneself, make it to play beyond thought effect, this health-care pu'er tea the more important thing is that it has very strong inhibitory action to AIDS virus HIV except that the effect with Pu'er tea self, and can obviously increase human body CD4 immunocyte quantity, and have no side effect.
The specific embodiment
Embodiment 1
Get material by following mass ratio:
300 kilograms of Pu'er raw teas
200 kilograms of the stems of noble dendrobium
100 kilograms of gensengs
100 kilograms in Poria cocos
The rhizoma Gastrodiae 120 kg
180 kilograms of glossy ganodermas
Through the applicant's the method for patent of invention formerly, that is:
A, the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material pulverizing is powdered, after Pu'er tea fully mixes, mixture;
B, be that 4.5 biology enzyme nutrient solution mixes with 1 ton of mixture of A step and 0.4 ton of water and 0.1 ton of pH value, wherein the biology enzyme nutrient solution is evenly mixed at normal temperatures by following component:
0.1 kilogram of bromelain
10 kilograms of glucose
15 kilograms of ciders
74.9 kilograms in water
C, B step gained mixture is deposited on the platen on the stand with the height of every layer of 40cm;
D, stand is placed in the fermenting cellar, the tea stack temperature is 40 ℃ on the console pallet plate, ferments 25 days, promptly gets health-care pu'er tea;
E, D step gained health-care pu'er tea is made the cake tea of health care products, promptly get AIDS virus resisting HIV, improve the health-care pu'er tea product of immune function of human body with the existing conventional processing method.
Embodiment 2
Get material by following mass ratio:
500 kilograms of Pu'er raw teas
100 kilograms of the stems of noble dendrobium
170 kilograms of gensengs
50 kilograms in Poria cocos
100 kilograms in rhizoma Gastrodiae
80 kilograms of glossy ganodermas
Through the applicant's the method for patent of invention formerly, that is:
A, the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material pulverizing is powdered, after Pu'er tea fully mixes, mixture;
B, be that 6.5 biology enzyme nutrient solution mixes with 1 ton of mixture of A step and 0.6 ton of water and 0.3 ton of pH value, wherein the biology enzyme nutrient solution is evenly mixed at normal temperatures by following component:
0.3 kilogram of papain
30 kilograms of glucose
30 kilograms of ciders
39.7 kilograms in water
C, B step gained mixture is deposited on the platen on the stand with the height of every layer of 70cm;
D, stand is placed in the fermenting cellar, the tea stack temperature is 60 ℃ on the console pallet plate, ferments 22 days, promptly gets health-care pu'er tea;
E, D step gained health-care pu'er tea is made the bag tea of health care products, promptly get AIDS virus resisting HIV, improve the health-care pu'er tea product of immune function of human body with the existing conventional processing method.
Embodiment 3
Get material by following mass ratio:
400 kilograms of Pu'er teas
140 kilograms of the stems of noble dendrobium
150 kilograms of gensengs
70 kilograms in Poria cocos
150 kilograms in rhizoma Gastrodiae
90 kilograms of glossy ganodermas
The following method of process:
A, earlier the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material are extracted through following method respectively: raw material pulverizing is powdered, be soaked in water 3 hours, heating is 4 hours under 80 ℃ of temperature, filter, concentrated filtrate, concentration is 30% extract;
B, be after 5.5 biology enzyme nutrient solution mixes, to mix with the full dose of each extract of A step gained with 400 kilograms of Pu'er teas and 80 kilograms of pH values, wherein, the biology enzyme nutrient solution is made up of following component by mass percent again:
0.2 kilogram of papain
20 kilograms of glucose
25 kilograms of fruit drinks
54.8 kilograms in water
C, B step gained mixture is packed into highly is in 0.8 meter the rectangular box, and under the situation of case mouth capping, temperature is under 40 ℃ of conditions in the control mixture heap, ferments 25 days, promptly gets health-care pu'er tea;
D, C step gained health-care pu'er tea is pressed into Tuo tea with the method for prior art, perhaps extract: health-care pu'er tea is ground into Powdered with the method for following prior art, be soaked in water 3 hours, heating is 4 hours under 80 ℃ of temperature, filter, concentrated filtrate, concentration is 80% extract, after allocating an amount of liquid glucose into, make oral liquid.
Embodiment 4
Get material by following mass ratio:
320 kilograms of Pu'er teas
110 kilograms of the stems of noble dendrobium
200 kilograms of gensengs
60 kilograms in Poria cocos
200 kilograms in rhizoma Gastrodiae
110 kilograms of glossy ganodermas
The following method of process:
A, earlier the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material are extracted through following method respectively: raw material pulverizing is powdered, be soaked in water 5 hours, heating is 2 hours under 80 ℃ of temperature, filter, concentrated filtrate, concentration is 50% extract;
B, be after 6 biology enzyme nutrient solution mixes, to mix with the full dose of each extract of A step gained with 320 kilograms of Pu'er teas and 96 kilograms of pH values, wherein, the biology enzyme nutrient solution is made up of following component by mass percent again:
0.3 kilogram of bromelain
15 kilograms of glucose
30 kilograms of fruit drinks
54.7 kilograms in water
C, B step gained mixture is packed into highly is in 1 meter the round box, and under the situation of case mouth capping, temperature is under 65 ℃ of conditions in the control mixture heap, ferments 20 days, promptly gets health-care pu'er tea;
D, C step gained health-care pu'er tea is extracted with the method for following prior art: health-care pu'er tea is ground into Powdered, was soaked in water 4 hours, heating is 3 hours under 80 ℃ of temperature, filter, concentrated filtrate, the gained filter cake carried out drying after, pack in the capsule material, get capsule.
For showing that health-care pu'er tea of the present invention has the effect of AIDS virus resisting HIV, will be verified by the test data that detects below:
I, material and method
One, measures medicine
The sample employing embodiment 3 gained concentration that detect test usefulness are 80% extract.Get this extract as testing sample, and it is dissolved in the RPMI-1640 complete medium, 0.22 μ m membrane filtration degerming, 4 ℃ of preservations, storage concentration is 5.0mg/ml.
Two, reagent and solution
(1) reagent
HEPES (N-2 (2-Hydroxyothyl) piperazine-N '-(2-ethanesufonic acid), MTT (3, (4,5-dimethylthiazol-2-y1)-2,5-diphenyl tetrazolium bromide), DMF (N, N '-Dimethyl formamine), penicillin (Penicillin), streptomycin sulphate (Streptomycin sulfate), glutamine (Glutamine) are all available from Sigma company; (2-ME 2-Mercaptoethan01) is Bio-Rad company product to 2 mercapto ethanol.RPMI-1640 and newborn calf serum are Gibeo company product.
(2) culture medium
The RPMI-1640 complete medium contains 10% newborn calf serum, 2mM L-glutamine, 10mM HEPES, 50 μ M2-mercaptoethanols, 100,000IU penicillin, 100 μ g/ml streptomysins.
Three, cell and virus
The human T lymphocyte is C8166, MT-4 and HIV-1 experiment strain HIV-1
IIIBBe so kind as to give by Britain MedicalResearchCouncil.AIDS Reagent Project.All cells and virus are all cultivated with the RPMI-1640 complete medium that contains 10% calf serum.Prepare HIV-1 according to a conventional method
IIIB, titration also calculates viral TCID
50Virus is put-70 ℃ of preservations after storing the liquid packing.The frozen according to a conventional method and recovery of cell and virus.
Four, HIV-1 infectious titration
HIV-1
IIIBPress Johnson﹠amp; The described method improvement of Byington (1990) carries out titration, is summarized as follows: HIV-1 is stored liquid on 96 orifice plates, do 4 times of dilutions, and 10 gradients, 6 repeating holes of every gradient are provided with control wells 6 holes simultaneously.Every hole: add C8166 cell 50 μ l, every hole final volume is 200 μ l.37 ℃, 5%CO
2Cultivate.Added fresh RPMI-1640 complete medium 1001 μ l on the 3rd day, under inverted microscope, observed cytopathic effect (the Cytopathic Effect that HIV-1 induces in every hole on the 7th day, CPE), whether there is the formation of plasomidum (Syncytium) to determine with every hole: to press Reed﹠amp; The Muench method is calculated the TCID of virus
50(50%Tissue Culture Infection Dose).
Five, to the toxicity test of C8166 cell
4 * 10
5/ ml C8166 cell suspension 100 μ l and different drug solution mixing to be measured establish 3 repeating holes.The control wells that does not contain medicine, 37 ℃, 5%CO are set simultaneously
2Cultivated 3 days, and adopted the MTT colorimetric method to detect cytotoxicity.The ELx800 ELIASA is measured the OD value, and the mensuration wavelength is 595nm, and reference wavelength is 630 nm.Calculate CC
50Value (50%Cytotoxic Concentration), the drug concentration during promptly to 50% normal T lymphocytic series C8166 toxigenicity.
Six, to HIV-1
IIIBThe inhibition experiment of cytopathogenic effect (CPE)
With 8 * 10
5/ ml C8166 cell 50 μ l/ holes are inoculated on the 96 porocyte culture plates that contain 100 μ l/ hole gradient doubling dilution medicines, add the HIV-1 of 50 μ l then
IIIBThe dilution supernatant, 1300 TCID
50/ hole.If 3 repeating holes.The normal cell control wells that does not contain medicine is set simultaneously.The positive medicine contrast of AZT.37 ℃, 5%CO
2Cultivated 3 days, (100 *) count plasmodial formation under the inverted microscope.EC
50(50%EffectiveConcentration) form 50% o'clock drug concentration for suppressing plasomidum.
Seven, to HIV-1
IIIBInfect the protection experiment of MT-4 cell death
On 96 porocyte culture plates, every kind of medicine is carried out 5 times of doubling dilutions, each dilution factor is established 4 holes, totally 6 dilution factors.Every hole 100 μ l.Not infection or the infected by HIV-1 that does not contain medicine is set simultaneously
IIIBThe cell control group.AZT is as the positive control medicine.2 holes in each dilution factor drip MT-4 cell suspension and HIV-1 respectively
IIIBEach 50 μ l of supernatant.2 holes drip MT-4 cell suspension 100 μ l in addition.Every hole final volume is 200 μ l.Put 37 ℃, 5%CO
2Cultivate in the incubator.Infect the back and added 100 μ l fresh cultures on the 3rd day.Measured OD with the MTT method with the ELx800 ELIASA on the 5th day
595/630The nm value.Calculate the inhibiting rate of medicine cell growth and to HIV-1
IIIBThe protective rate of infection cell.CC
50For to the toxigenous drug concentration of 50% host cell; EC
50For protecting 50% HIV-1
IIIBDrug concentration during the infection cell survival.
Eight, computing formula
Draw dose-effect curve according to experimental result, press Reed﹠amp; The Muench method calculates the 50% valid density (EC that compound suppresses virus
50), 50% suppresses cell growth concentration (CC
50) and the therapeutic index TI value (Therapeutic index) of anti-HIV-1 activity be: TI=CC
50/ EC
50
1, cell growth survival rate (%)=experimental port OD value/control wells OD value * 100
2, the cytopathogenic inhibiting rate of HIV-1 (%)=(1-experimental port plasomidum number/control wells plasomidum number) * 100
3, compound is to protective rate (%)=(experimental port OD value-HIV infection cell control wells OD value)/(normal cell control wells OD value HIV infection cell control wells 0D value) * 100 of HIV-1 infection cell
II, result
One, the cytotoxic effect of health-care pu'er tea extract
The health-care pu'er tea extract to the experimental data of the toxic action of C8166 cell see Table 1, Fig. 1.
CC
50(the health-care pu'er tea extract is tested for the first time): 378.26 μ g/ml; CC
50(the health-care pu'er tea extract is tested for the second time): 377.83 μ g/ml; CC
50(AZT) be: 1389.95 μ g/ml.
Two, the health-care pu'er tea extract is to HIV-1
IIIBInduce the cytopathic inhibitory action of C8166
The health-care pu'er tea extract is to HIV-1
IIIBInduce that the cytopathic inhibitory action experimental data of C8166 sees Table 2, Fig. 2.
EC
50(the health-care pu'er tea extract is tested for the first time): 11.62 μ g/ml; EC
50(the health-care pu'er tea extract is tested for the second time): 11.53 μ g/ml; EC
50(AZT) be: 4.01 μ g/ml
Three, the health-care pu'er tea extract is to HIV-1
IIIBInfect the protection experiment of MT-4 cell death
The health-care pu'er tea extract is to HIV-1
IIIBThe protection experimental data that infects the MT-4 cell death sees Table 3, Fig. 3.
CC
50(the health-care pu'er tea extract is tested for the first time): 93 μ g/ml; CC
50(the health-care pu'er tea extract is tested for the second time): 93.15 μ g/ml, EC
50(the health-care pu'er tea extract is tested for the first time): 19.88 μ g/ml; EC
50(the health-care pu'er tea extract is tested for the second time): 13.62 μ g/ml.CC
50(AZT)＞1 μ g/ml; EC
50(AZT) be 0.0036 μ g/ml.
III, experimental result
The active settlement of exchange of health-care pu'er tea extract cytotoxicity and anti-HIV-1 summary table sees Table 4.
IV, conclusion
The health-care pu'er tea extract has certain toxicity, CC to the C8166 cell
50Be 377.83～378.26 μ g/ml, induce the C8166 cell to form plasomidum to HIV-1 and suppress better active; EC
50Be 11.53～11.62 μ g/ml, therapeutic index (TI) is 32.55～32.76.The health-care pu'er tea extract infects the MT-4 cell to HIV-1 and has certain protective role, its EC
50Be 13.62～19.88 μ g/ml, therapeutic index (TI) value is 4.68～6.84.Illustrate that this health-care pu'er tea has external anti-HIV-1 activity, its therapeutic index is 32.55～32.76.HIV-1 is infected the MT-4 cell certain protection effect is arranged.
For showing that health-care pu'er tea of the present invention has the curative effect of treatment AIDS virus HIV, below will be by its effect of clinical observation:
One, physical data
Selection meets patient's 80 examples of country's free AIDS virus resisting treatment medical science inclusion criteria, wherein, the male sex's 60 examples, women's 20 examples, the age is at 19-65 between year, average 24.5 years old, at random 80 routine patients are divided into two groups, the medicine of the single clothes of control group 40 examples AIDS virus resisting, test group 40 examples add the cake tea that the embodiment of the invention 1 provides in the clothes AIDS virus resisting medicine identical with control group.Both at aspects such as clinical manifestation, sex, ages by statistics credit analyse there was no significant difference (P＞0.05).
Two, methods of treatment
All patient's antiviral therapy schemes all adopt standard one line scheme, promptly national free AIDS antiviral therapy handbook (D4T+3TC+NVP or EFV), and test group adds the cake tea that the embodiment of the invention 1 provides, one time 5 gram, boiling water brews, every day 3 times, total 4 months courses of treatment.
Three, observation index
Observation index comprises clinical symptoms, sign and laboratory indexes.Understand patient's medicine toxicity situation and assessment curative effect.Monitored body weight, CBC, blood sugar, creatinine, ALT etc., and monitored CD4 per February in every month
+Cell number.
Four, result
Test group toxicity incidence is starkly lower than control group, particularly symptom of digestive tract and hepatotoxicity wind agitation incidence, and two groups of contrasts have notable difference (P＞0.05), see table 1 for details.Test group CD4
+The cell count climbing is higher than control group, sees table 2 for details.
A situation arises for table 1 toxicity
| Group | Symptom of digestive tract | Hepatotoxicity wind agitation | Fash | Peripheral neuritis | Bone marrow suppression |
| Test group (40 example) | 10 examples (25%) | 2 examples (5%) | 4 examples (20%) | 2 examples (5%) | 0 example |
| Control group (40 example) | 24 examples (60%) | 10 examples (25%) | 6 examples (15%) | 2 examples (5%) | 0 example |
(P＞0.05)
The assessment of table 2 curative effect
| Group | CD4 +The cell count climbing | Opportunistic infections are sent out again |
| Test group (40 example) | 36 examples (90%) [the highest rising 426/mm 3] | 0 example |
| Control group (40 example) | 24 examples (70%) | 8 examples (20%) |
(P＞0.05)
Five, discuss
Composition in the health-care pu'er tea can slow down the damage of immunocyte, promotes the recovery of impaired immunocyte, adjusts effects such as intestinal absorption environment, and can improve the human immune system, gastrointestinal absorption.From this case research result, health-care pu'er tea can reduce toxicity incidence, particularly symptom of digestive tract and the hepatotoxicity wind agitation that the patient takes the AIDS virus resisting medicine, improves the compliance that the patient takes medicine, thereby improves the curative effect of antiviral therapy.This test group CD4
+The cell count climbing is higher than control group.
Claims (10)
- An AIDS virus resisting HIV, improve the health-care pu'er tea of immune function of human body, it is characterized in that forming by the raw material of following mass ratio:Pu'er tea 30～50%The stem of noble dendrobium 10～20%Genseng 10～20%Poria cocos 5～10%Rhizoma Gastrodiae 10～20%Glossy ganoderma 8～18%.
- 2. the health-care pu'er tea of a kind of AIDS virus resisting HIV according to claim 1, raising immune function of human body is characterized in that described health-care pu'er tea makes through following method:A, elder generation extract the stem of noble dendrobium, genseng, Poria cocos, rhizoma Gastrodiae, glossy ganoderma raw material respectively through following method: raw material pulverizing is powdered, be soaked in water 3～5 hours, and under 80 ℃ of temperature, heated 2～4 hours, filter, concentrated filtrate, concentration is 30～50% extract;B, Pu'er tea and biology enzyme nutrient solution mixed by 1: 0.1～0.3 mass ratio after, mix with the full dose of each extract of A step gained again, wherein, the biology enzyme nutrient solution is made up of following component by mass percent:Hydrolysising protease 0.1～0.3%Glucose 10～35%Fruit drink 15～30%Water surplus;C, B step gained mixture is packed in the case, temperature is under the 40-65 ℃ of condition in the mixture heap, ferments 20-25 days, promptly gets health-care pu'er tea;D, step C gained fermented health-care Pu'er tea is made loose tea, fannings, cake tea, Tuo tea, sugar tea, the tea in bag of health care products, promptly get AIDS virus resisting HIV, improve the health-care pu'er tea product of immune function of human body.
- 3. the health-care pu'er tea of a kind of AIDS virus resisting HIV according to claim 1, raising immune function of human body, the vanning fermentation employing that it is characterized in that described C step highly is the rectangle of 0.8-1 rice or circle or polygon casing, and ferments under the situation of case mouth capping.
- 4. a kind of AIDS virus resisting HIV according to claim 1, improve the health-care pu'er tea of immune function of human body, the hydrolysising protease that it is characterized in that described B step is a kind of in bromelain, the papain; Fruit drink is one or more in pear juice, cider, peach juice, watermelon juice, pineapple juice, mango juice, grape juice, Passiflora juice, Cantaloupe juice, Chinese flowering quince juice, orange juice, the juice of my pomegranate.
- 5. the health-care pu'er tea of a kind of AIDS virus resisting HIV according to claim 1, raising immune function of human body, the pH value that it is characterized in that the biology enzyme nutrient solution of described B step is 4.5～6.5.
- 6. the health-care pu'er tea of a kind of AIDS virus resisting HIV according to claim 1, raising immune function of human body, it is characterized in that the humidity control in the described sweat is 10～30% to exceed with material moisture, water content many and few are decided by the moisture of material in the water content of solar dried green tea and other raw material self and the sweat again.
- 7. the health-care pu'er tea of a kind of AIDS virus resisting HIV according to claim 1, raising immune function of human body is characterized in that described Pu'er tea is the solar dried green tea of big-leaf species in yunnan tea, has another name called Pu'er raw tea.
- 8. a kind of AIDS virus resisting HIV according to claim 1 and 2, improve the health-care pu'er tea of immune function of human body, it is characterized in that above-mentioned health-care pu'er tea and other prevent and treat the drug regimen of AIDS and make the loose tea of compound health-care category, fannings, cake tea, Tuo tea, sugar tea, tea in bag.
- According to claim 1 or 2 or 3 described a kind of AIDS virus resisting HIV, improve the health-care pu'er tea of immune function of human body, after it is characterized in that described health-care pu'er tea extracts by the conventional method of prior art, the conventional method that adopts prior art again is the extract obtained oral formulations that is prepared into the capsule that allows on the pharmacy, tablet, electuary, oral liquid, perhaps is prepared into the ejection preparation of the parenteral solution that allows on the pharmacy, powder ampoule agent for injection, injection emulsion.
- According to claim 1 or 2 or 3 described a kind of AIDS virus resisting HIV, improve the health-care pu'er tea of immune function of human body, it is characterized in that described health-care pu'er tea extract can make compound oral administration preparation or the compound injection that allows on the pharmacy with other drug regimens of preventing and treating AIDS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100580228A CN101213998B (en) | 2008-01-10 | 2008-01-10 | Health care pu'er tea capable of resisting HIV virus and improving human body immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100580228A CN101213998B (en) | 2008-01-10 | 2008-01-10 | Health care pu'er tea capable of resisting HIV virus and improving human body immunity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101213998A true CN101213998A (en) | 2008-07-09 |
| CN101213998B CN101213998B (en) | 2011-03-16 |
Family
ID=39620546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100580228A Expired - Fee Related CN101213998B (en) | 2008-01-10 | 2008-01-10 | Health care pu'er tea capable of resisting HIV virus and improving human body immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101213998B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101911989A (en) * | 2010-08-03 | 2010-12-15 | 马伟光 | Truffle health-care tea and preparation method thereof |
| CN103988943A (en) * | 2014-05-15 | 2014-08-20 | 陈荣达 | Pericarpium citri reticulatae, Pu'er and Se-enriched rice tea |
| CN104544363A (en) * | 2015-01-29 | 2015-04-29 | 贵州紫荆生物科技有限公司 | Dendrobium sour soup composition and preparation method thereof |
| CN105010629A (en) * | 2015-06-26 | 2015-11-04 | 普洱和聚诚生物科技发展有限公司 | Anoectochilus roxburghii containing pu-er tea |
| CN105851390A (en) * | 2016-05-08 | 2016-08-17 | 铜仁学院 | Rhizoma gastrodiae, Flos chrysanthemi and Momordica grosvenori tea and making method thereof |
| CN106538745A (en) * | 2017-01-23 | 2017-03-29 | 高凤玲 | A kind of ripe tea production technology of Pu'er tea and ginseng mixture |
| CN108077477A (en) * | 2017-12-19 | 2018-05-29 | 福建农林大学 | A kind of health care Pu'er tea bagged tea and its processing technology |
| CN112690347A (en) * | 2020-12-19 | 2021-04-23 | 云南大学 | Method for fermenting Pu' er tea by using ganoderma lucidum fungi |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100361589C (en) * | 2005-03-02 | 2008-01-16 | 王乐观 | Pu'er health care tea and its preparation method |
| CN100364430C (en) * | 2006-01-11 | 2008-01-30 | 王乐观 | Method for pu'er tea fermented by biological enzyme |
-
2008
- 2008-01-10 CN CN2008100580228A patent/CN101213998B/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101911989A (en) * | 2010-08-03 | 2010-12-15 | 马伟光 | Truffle health-care tea and preparation method thereof |
| CN103988943A (en) * | 2014-05-15 | 2014-08-20 | 陈荣达 | Pericarpium citri reticulatae, Pu'er and Se-enriched rice tea |
| CN104544363A (en) * | 2015-01-29 | 2015-04-29 | 贵州紫荆生物科技有限公司 | Dendrobium sour soup composition and preparation method thereof |
| CN105010629A (en) * | 2015-06-26 | 2015-11-04 | 普洱和聚诚生物科技发展有限公司 | Anoectochilus roxburghii containing pu-er tea |
| CN105851390A (en) * | 2016-05-08 | 2016-08-17 | 铜仁学院 | Rhizoma gastrodiae, Flos chrysanthemi and Momordica grosvenori tea and making method thereof |
| CN106538745A (en) * | 2017-01-23 | 2017-03-29 | 高凤玲 | A kind of ripe tea production technology of Pu'er tea and ginseng mixture |
| CN108077477A (en) * | 2017-12-19 | 2018-05-29 | 福建农林大学 | A kind of health care Pu'er tea bagged tea and its processing technology |
| CN108077477B (en) * | 2017-12-19 | 2021-04-20 | 福建农林大学 | Health-care Pu' er tea bag and processing technology thereof |
| CN112690347A (en) * | 2020-12-19 | 2021-04-23 | 云南大学 | Method for fermenting Pu' er tea by using ganoderma lucidum fungi |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101213998B (en) | 2011-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101213998B (en) | Health care pu'er tea capable of resisting HIV virus and improving human body immunity | |
| CN101485463B (en) | Natural product composing prescription with various health-care efficacies | |
| CN101411372B (en) | Health-care tea and its preparing process | |
| CN104491350B (en) | A kind of health products for adjusting cardiovascular and cerebrovascular health and reducing cardiovascular and cerebrovascular disease risk | |
| CN102396615A (en) | Red date blood tonifying assorted Chinese herbal tea drink and preparation method thereof | |
| CN103211257B (en) | A kind of hypoglycemic apple vinegar health beverage and preparation method thereof | |
| CN103169737B (en) | Composite of Antrodia camphorata entity and shell-broken ganoderma lucidum spore powder and application thereof in immune adjustment | |
| CN107904103A (en) | A kind of dendrobium candidum health liquor and its preparation method and application | |
| CN103585400A (en) | Composition having immunity enhancing and fatigue alleviating effects, and preparation method thereof | |
| CN101332256B (en) | Traditional Chinese medicine composition for infectious bursal disease and preparation method thereof | |
| CN102613331A (en) | Halimasch fermented tea and halimasch fermented tea composition, and preparation methods thereof | |
| CN103908489A (en) | Bidirectional solid fermentation method of ginseng-radix astragali-lucid ganoderma medical mycoplasm | |
| CN101991713A (en) | Medicament containing raw materials of Pu'er tea and worm grass | |
| CN109350709A (en) | A kind of herb mixture and preparation method thereof of the anti-curing oncoma of hypoglycemic | |
| CN106309506A (en) | Probiotic composition with menstruation regulating function and application thereof | |
| EP2842433B1 (en) | Food for nutritional therapy of aids | |
| CN101664086B (en) | Black tea drink capable of enhancing organism immunity, lowering blood lipid, losing weight and improving beautifying function | |
| CN102552469A (en) | Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension | |
| CN101011468A (en) | Yixinningshen tablet and its preparation method | |
| CN101991722B (en) | Shiqi exogenous disease-treating traditional Chinese medicinal capsules | |
| CN111700926A (en) | Millettia speciosa champ extract, preparation method thereof and application thereof in medicines for reducing blood fat and losing weight | |
| CN104273527B (en) | A kind of health composition and its production and use | |
| CN108478715A (en) | A kind of Chinese medicine composition is preparing the application in treating children's hyperkinetic syndrome drug | |
| CN107699501A (en) | A kind of culture medium of Hericium erinaceus, bioconversion mycelium, the mycelial extract of bioconversion and application thereof | |
| CN102805341A (en) | Five-time fermentation preparation method of Chinese yam, radix astragali and salviae miltiorrhizae capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Tianfu tea trade limited liability company Assignor: Wang Leguan Contract record no.: 2011530000053 Denomination of invention: Health care pu'er tea capable of resisting HIV virus and improving human body immunity Granted publication date: 20110316 License type: Exclusive License Open date: 20080709 Record date: 20110720 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110316 Termination date: 20190110 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |